|
1
|
Chihara M, Kurita M, Yoshihara Y, Asahina
A and Yanaba K: Clinical significance of serum galectin-9 and
soluble CD155 levels in patients with systemic sclerosis. J Immunol
Res. 2018(9473243)2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Cottin V and Brown KK: Interstitial lung
disease associated with systemic sclerosis (SSc-ILD). Respir Res.
20(13)2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Butt SA, Jeppesen JL, Fuchs C, Mogensen M,
Engelhart M, Torp-Pedersen C, Gislason GH, Jacobsen S and Andersson
C: Trends in incidence, mortality, and causes of death associated
with systemic sclerosis in Denmark between 1995 and 2015: A
nationwide cohort study. BMC Rheumatol. 2(36)2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Friedrich S, Lüders S, Glimm AM, Werner
SG, Schmittat G, Burmester GR, Backhaus M, Riemekasten G and
Ohrndorf S: Association between baseline clinical and imaging
findings and the development of digital ulcers in patients with
systemic sclerosis. Arthritis Res Ther. 21(96)2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
McFarlane IM, Bhamra MS, Kreps A, Iqbal S,
Al-Ani F, Saladini-Aponte C, Grant C, Singh S, Awwal K, Koci K, et
al: Gastrointestinal manifestations of systemic sclerosis.
Rheumatology (Sunnyvale). 8(235)2018.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Altorok N, Wang Y and Kahaleh B:
Endothelial dysfunction in systemic sclerosis. Curr Opin Rheumatol.
26:615–620. 2014.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Liakouli V, Elies J, El-Sherbiny YM,
Scarcia M, Grant G, Abignano G, Derrett-Smith EC, Esteves F,
Cipriani P, Emery P, et al: Scleroderma fibroblasts suppress
angiogenesis via TGF-β/caveolin-1 dependent secretion of pigment
epithelium-derived factor. Ann Rheum Dis. 77:431–440.
2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Grigore O, Mihailescu AI, Solomon I, Boda
D and Caruntu C: Role of stress in modulation of skin neurogenic
inflammation. Exp Ther Med. 17:997–1003. 2019.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Ilie MA, Caruntu C, Lixandru D, Tampa M,
Georgescu SR, Constantin MM, Constantin C, Neagu M, Zurac SA and
Boda D: In vivo confocal laser scanning microscopy imaging
of skin inflammation: Clinical applications and research
directions. Exp Ther Med. 17:1004–1011. 2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Ilie MA, Caruntu C, Tampa M, Georgescu SR,
Matei C, Negrei C, Ion RM, Constantin C, Neagu M and Boda D:
Capsaicin: Physicochemical properties, cutaneous reactions and
potential applications in painful and inflammatory conditions. Exp
Ther Med. 18:916–925. 2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Ghiţă MA, Căruntu C, Rosca AE, Căruntu A,
Moraru L, Constantin C, Neagu M and Boda D: Real-time investigation
of skin blood flow changes induced by topical capsaicin. Acta
Dermatovenerol Croat. 25:223–227. 2017.PubMed/NCBI
|
|
12
|
Manetti M, Pratesi S, Romano E, Rosa I,
Bruni C, Bellando-Randone S, Guiducci S, Maggi E, Ibba-Manneschi L
and Matucci-Cerinic M: Decreased circulating lymphatic endothelial
progenitor cells in digital ulcer-complicated systemic sclerosis.
Ann Rheum Dis. 78:575–577. 2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Tatu AL and Nwabudike LC: The treatment
options of male genital lichen sclerosus et atrophicus: Treatments
of genital lichen sclerosus. In: 14th National Congress of
Urogynecology (Urogyn), Eforie, Romania, 262-264, 2017.
|
|
14
|
Tatu AL and Ionescu MA: Multiple
autoimmune syndrome type III-thyroiditis, vitiligo and alopecia
areata. Acta Endocrinol (Bucharest). 13:124–125. 2017.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Kahaleh MB: Raynaud phenomenon and the
vascular disease in scleroderma. Curr Opin Rheumatol. 16:718–722.
2004.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Denton CP: Advances in pathogenesis and
treatment of systemic sclerosis. Clin Med (Lond). 15 (Suppl
6):s58–s63. 2015.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Codullo V, Distler O and Montecucco C:
Pathophysiology of systemic sclerosis. In: Novel Insights into
Systemic Sclerosis Management. Publisher Future Medicine Ltd.,
London, pp22-35, 2013.
|
|
18
|
Nwabudike LC and Tatu AL: Magistral
prescription with silver nitrate and Peru Balsam in difficult to
heal diabetic foot ulcers. Am J Ther. 25:e679–e680. 2018.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Guillevin L, Hunsche E, Denton CP, Krieg
T, Schwierin B, Rosenberg D and Matucci-Cerinic M: DUO Registry
Group. Functional impairment of systemic scleroderma patients with
digital ulcerations: Results from the DUO Registry. Clin Exp
Rheumatol. 31 (Suppl 76):71–80. 2013.PubMed/NCBI
|
|
20
|
Gheorghe I, Tatu AL, Lupu I, Thamer O,
Cotar AI, Pircalabioru GG, Popa M, Cristea VC, Lazar V and
Chifiriuc MC: Molecular characterization of virulence and
resistance features in Staphylococcus aureus clinical
strains isolated from cutaneous lesions in patients with drug
adverse reactions. Rom Biotechnol Lett. 22:12321–12327. 2017.
|
|
21
|
Ilie MA, Caruntu C, Lupu M, Lixandru D,
Tampa M, Georgescu SR, Bastian A, Constantin C, Neagu M, Zurac SA,
et al: Current and future applications of confocal laser scanning
microscopy imaging in skin oncology. Oncol Lett. 17:4102–4111.
2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Herrick A and Muir L: Raynaud's phenomenon
(secondary). BMJ Clin Evid: pii: 1125, 2014.
|
|
23
|
Cutolo M, Sulli A, Pizzorni C and Accardo
S: Nailfold videocapillaroscopy assessment of microvascular damage
in systemic sclerosis. J Rheumatol. 27:155–160. 2000.PubMed/NCBI
|
|
24
|
Tatu AL and Cristea VC: Pityriasis
folliculorum of the back thoracic area: Pityrosporum, keratin
plugs, or demodex involved? J Cutan Med Surg.
21(441)2017.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Nwabudike LC and Tatu AL: Response to -
Chronic exposure to tetracyclines and subsequent diagnosis for
non-melanoma skin cancer in a large Mid-Western US population. J
Eur Acad Dermatol Venereol. 32(e 159)2018.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Tatu AL and Cristea VC: Unilateral
blepharitis with fine follicular scaling. J Cutan Med Surg.
21(442)2017.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Tatu AL and Nwabudike LC: Reply to: Kubiak
K et al: Endosymbiosis and its significance in dermatology.
J Eur Acad Dermatol Venereol. 32:e346–e347. 2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Tatu AL, Clatici VG and Nwabudike LC:
Rosacea-like demodicosis (but not primary demodicosis) and
papulopustular rosacea may be two phenotypes of the same disease -
a microbioma, therapeutic and diagnostic tools perspective. J Eur
Acad Dermatol Venereol. 33:e46–e47. 2019.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Tatu AL, Ionescu MA and Nwabudike LC:
Contact allergy to topical mometasone furoate confirmed by
rechallenge and patch test. Am J Ther. 25:e497–e498.
2018.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Tatu AL, Ciobotaru OR, Miulescu M, Buzia
OD, Elisei AM, Mardare N, Diaconu C, Robu S and Nwabudike LC:
Hydrochlorothiazide: Chemical structure, therapeutic, phototoxic
and carcinogenetic effects in dermatology. Rev Chim (Bucharest).
69:2110–2114. 2018.
|
|
31
|
Nwabudike LC, Elisei AM, Buzia OD,
Miulescu M and Tatu AL: Statins. A review on structural
perspectives, adverse reactions and relations with non-melanoma
skin cancer. Rev Chim (Bucharest). 69:2557–2562. 2018.
|
|
32
|
Tatu AL, Elisei AM, Chioncel V, Miulescu M
and Nwabudike LC: Immunologic adverse reactions of β-blockers and
the skin (Review). Exp Ther Med. 18:955–959. 2019.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Nwabudike LC, Miulescu M and Tatu AL: Case
series of an alternative therapy for generalised lichen planus:
Four case studies. Exp Ther Med. 18:943–948. 2019.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Ciobotaru OR, Lupu MN, Rebegea L,
Ciobotaru OC, Duca OM, Tatu AL, Voinescu CD, Stoleriu G, Earar K
and Miulescu M: Dexamethasone - chemical structure and mechanisms
of action in prophylaxis of postoperative side effects. Rev Chim
Buchar. 70:843–847. 2019.
|
|
35
|
Kanno Y, Shu E, Kanoh H and Seishima M:
The antifibrotic effect of α2AP neutralization in systemic
sclerosis dermal fibroblasts and mouse models of systemic
sclerosis. J Invest. 136:762–769. 2016.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Vikse J, Gøransson LG and Norheim KB:
Systemic capillary leak syndrome following bosentan treatment in a
patient with systemic sclerosis. Scand J Rheumatol. 48:426–427.
2019.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Bobeică C, Crăescu M, Ancuța CI, Coman M
and Nechita A: Experimental models for the study of systemic
scleroderma In: Annals of the University ‘Dunarea de Jos’ of
Galati, Fascicle XVII. Galati University Press. 71–84. 2018.
|
|
38
|
Bobeică C, Vâță D, Stătescu L, Țăranu T,
Popescu IA, Grăjdeanu AI and Gheucă-Solovăstru L: The quality of
life for a patient with an autoimmune disease. Bull Integr
Psychiatry. XXV:27–36. 2019.
|
